Gene description for ADAM9 |
Gene name |
ADAM metallopeptidase domain 9 |
Gene symbol |
ADAM9 |
Other names/aliases |
CORD9 MCMP MDC9 Mltng |
Species |
Homo sapiens |
Experiment description of studies that identified ADAM9 in Glioblastoma cells |
1
|
Experiment ID | 722 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25802036
|
Organism | Homo sapiens |
Experiment description | Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. |
Authors | de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, Dekker L, Luider TM, de Witte LD, Litjens M, van Strien ME, Hol EM, Kroonen J, Robe PA, Lamfers ML, Schilham MW, Broekman ML. |
Journal name |
Int J Cancer
|
Publication year | 2015 |
Sample | Glioblastoma cells |
Sample name | U87.MG/EGFRvIII |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV150064: EV-METRIC:0%, 0%, 29%
|
|
|
2
|
Experiment ID | 723 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25802036
|
Organism | Homo sapiens |
Experiment description | Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. |
Authors | de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, Dekker L, Luider TM, de Witte LD, Litjens M, van Strien ME, Hol EM, Kroonen J, Robe PA, Lamfers ML, Schilham MW, Broekman ML. |
Journal name |
Int J Cancer
|
Publication year | 2015 |
Sample | Glioblastoma cells |
Sample name | GS184 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV150064: EV-METRIC:0%, 0%, 29%
|
|
|